Abiopharma

Net Asset Value(s)

Net Asset Value(s)

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Mariel von Schumann

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Astrid Skarheim Onsum

Organon & Co. - Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE®(tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Sarjit Singh Gill

Smoothie King Drives Incremental Revenue and Loyalty Engagement with PAR Games in First Three Months

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

LTM Introduces BlueVerse™ Currency to Enable Outcome-Based Pricing in the Agentic AI Era